FROM OUR BLOG

Switchboard Buys Livara; Bessent vs. Fed Rocks Bond Markets

Switchboard Health acquires Livara for MSK care plus a $5M raise, as Treasury-Fed tensions and Nvidia earnings rattle global markets.

August 26, 2026

Healthcare Practice & Business Deals

Modern medical office interior design
“Modern medical office interior design”, by Shixart1985, licensed under BY 2.0, via source

One specific small-to-medium healthcare deal emerged from this week’s news flow, while the broader candidate list was dominated by regulatory, clinical, and workforce stories with no qualifying named transactions.

Switchboard Health Acquires Livara Health — $5M Funding Round Secured: Switchboard Health has acquired Livara Health, a value-based musculoskeletal (MSK) care company, and simultaneously closed a $5 million funding round. Switchboard plans to embed Livara’s MSK program directly into its automation platform, which focuses on referral management and care navigation. The deal expands Switchboard’s clinical capabilities while giving the combined entity fresh capital to accelerate deployment. Financial terms of the acquisition itself were not disclosed.

No Qualifying Deal Among Remaining Candidates: The rest of this week’s healthcare candidates — including the Samaritan Health Services / MultiCare merger (an 18-hospital, $7.5B-revenue system combination that qualifies as a large health-system deal), biopharma FDA approvals, AI scribe product launches, and workforce and regulatory stories — do not meet the small-to-medium independent or group practice acquisition criteria for this section. No additional qualifying named transactions were available in the sourced material this week.

Global Markets & Macro

Placeholder
“Placeholder”, by ehnmark, licensed under BY 2.0, via source

Markets are navigating a tense intersection of Fed policy uncertainty, Treasury intervention debate, and a pivotal earnings event, with Jackson Hole and a key inflation reading setting the tone for the week.

Stocks and Treasuries Slip Ahead of Nvidia and PCE Data: U.S. equities struggled for direction and Treasury prices eased as traders pulled back from risk ahead of two major catalysts: earnings from Nvidia and July’s reading of the Federal Reserve’s preferred inflation gauge, the PCE index. The cautious mood reflects how much weight markets are placing on both data points as indicators of the pace of future rate moves.

Bessent’s Bond Buybacks Put Treasury on Collision Course with Fed: A major flashpoint this week is the tension between Treasury Secretary Scott Bessent and Fed Chair Kevin Warsh. The Financial Times reports that increased Treasury purchases of debt threaten to undermine Warsh’s efforts to tame inflation — a dynamic that has drawn sharp commentary from prominent investors. Morgan Stanley Investment Management’s Vishal Khanduja, described as a top-performing fixed-income investor, disclosed he is scaling back bets against long-term U.S. bonds, citing Bessent’s apparent readiness to do “whatever it takes” to keep yields from rising. Separately, Pimco’s Andrew Balls pointed to low volatility as a sign of a “healthy” bond market, though he said it is “not 100% clear” why the Treasury would increase purchases of long-dated bonds.

Gold Pulls Back as Jackson Hole Focus Sharpens: Gold retreated from a three-month high as investors rotated attention toward the Federal Reserve’s annual Jackson Hole gathering and the rate path signals expected to emerge from it. The pullback followed a five-day rally, with inflation expectations and the upcoming PCE print the key variables traders are watching.

Global Fuel Markets Under Pressure: Bloomberg flags that global fuel markets have “little margin for error,” with the world increasingly reliant on U.S. refineries that are operating near their limits. The strain adds an energy-cost dimension to the inflation picture that central bankers at Jackson Hole will need to factor into their guidance. In the U.K., household energy bills are set to hit a three-year high from October, with the price cap rising 4% to £1,723 per year, driven in part by Middle East conflict dynamics.

ECB Signals Further Rate Increases: On the European side, ECB Governing Council member Isabel Schnabel emphasized the need for further interest rate increases, citing upside inflation risks — a hawkish signal that aligns with the broader global central-bank tightening narrative heading into the Jackson Hole week.

What to Watch

For healthcare practice owners and advisors, the Switchboard-Livara deal is a reminder that value-based care and MSK platforms continue to attract both strategic buyers and venture capital even as deal volume fluctuates week to week; with employer healthcare costs projected to rise as much as 9.2% in 2027, payers and plan sponsors will keep pressing providers on efficiency — a dynamic that favors practices with demonstrable outcomes data. On the macro side, the twin catalysts of Nvidia’s earnings and the July PCE print will either validate or rattle the market’s current fragile calm: a hotter-than-expected inflation reading could force the Fed’s hand on rates, while the Bessent-Warsh tension over Treasury buybacks introduces a policy-coordination risk that bond and equity markets have not fully priced. Jackson Hole guidance will be the week’s defining moment for rate-sensitive assets — and for the financing conditions that underpin healthcare M&A activity heading into the fall.


Editorial note, image use & corrections. This report is compiled and summarized from publicly available news sources; figures and details should be independently verified. Accompanying images are used under Creative Commons or public-domain licenses (sourced via Openverse) and credited where required. If you believe any content — written or image — has been used in error, is inaccurate, or infringes your rights, or you wish to request a correction or removal, please contact us at info@tenetma.com and we will address it promptly.

THINKING ABOUT SELLING YOUR MEDICAL PRACTICE?

Get a confidential practice valuation.

If you’re considering selling your practice — or exploring your options — a confidential valuation is a helpful first step. Understanding market conditions and potential value provides clarity and supports better decisions around timing and strategy.

START THE CONVERSATION

If you’re considering a sale, exploring acquisitions or planning ahead,
we’re here to help.

Schedule a confidential consultation to learn how our services can support your goals.